Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2013
TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN productionFinlay W McNab, John Ewbank, Ricardo Rajsbaum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2011
NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activationHuei-Ting Yang, Yanyan Wang, Xixing Zhao, et al.
Haematologica|December 31, 2011
A20 inactivation in ocular adnexal MALT lymphomaYingwen Bi, Naiyan Zeng, Estelle Chanudet, et al.
Journal of Cardiothoracic and Vascular Anesthesia|September 1, 1999
Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: a multicenter observational study. Multicenter Study of Perioperative Ischemia Research GroupS C Body, J Birmingham, R Parks, et al.
The Biochemical Journal|December 13, 2017
Assaying kinase activity of the TPL-2/NF-κB1 p105/ABIN-2 complex using an optimal peptide substrateSandra Kümper, Thorsten Gantke, Chao-Sheng Chen, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2016
Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cellsYashaswini Kannan, Yanda Li, Stephanie M Coomes, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activationAna Risco, Carlos del Fresno, Agnes Mambol, et al.
Elife|July 17, 2023
p38γ and p38δ modulate innate immune response by regulating MEF2D activationAlejandra Escós, Ester Diaz-Mora, Michael Pattison, et al.
The Journal of Clinical Investigation|November 9, 2000
Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditisL McLaughlin, G Zhu, M Mistry, et al.
Head and Neck Pathology|December 28, 2016
Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell CarcinomaJonathan Chatzkel, James S Lewis, Jessica C Ley, et al.
Pageof 18